Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-28

FDA Approved: SEVELAMER CARBONATE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals’ generic Sevelamer carbonate (Original Application) for the treatment of hyperphosphatemia in adults with chronic kidney dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

ORIG AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)